Cancer Treatment

Rhabdomyosarcoma

4 min read
Image of lungs

Rhabdomyosarcoma

Rhabdomyosarcoma (RMS) is a rare type of cancer that forms in the soft tissues of the body, such as muscles, tendons, and connective tissues. It is most commonly found in children and adolescents, but it can also occur in adults. RMS accounts for approximately 3% of all childhood cancers and is diagnosed in about 350 children in the United States each year.

Epidemiology

Rhabdomyosarcoma can occur anywhere in the body, but it is most commonly found in the head and neck area, as well as in the genitourinary tract, including the bladder, vagina, and prostate. The exact cause of RMS is still unknown, but some genetic and environmental factors may increase the risk of developing this cancer. Children with certain genetic disorders, such as Li-Fraumeni syndrome and neurofibromatosis type 1, are at a higher risk of developing RMS.

Diagnosis

Diagnosing rhabdomyosarcoma usually involves a combination of medical history evaluation, physical examinations, imaging tests, and biopsy. Medical professionals will assess the symptoms, look for any lumps or tumors, and order tests such as X-rays, CT scans, MRI scans, and PET scans to determine the location and extent of the cancer. A biopsy is then performed to confirm the diagnosis by examining the tissue under a microscope.

Treatment

The treatment options for rhabdomyosarcoma depend on various factors, including the location of the tumor, the stage of the cancer, and the overall health of the patient. The main treatment modalities for RMS include surgery, radiation therapy, and chemotherapy.

Surgery is often the initial step in treating RMS. It aims to remove the tumor and surrounding affected tissues. Depending on the size and location, surgical options may include complete tumor removal or partial excision to reduce the tumor's size before additional treatments. In some cases, reconstructive surgery may be necessary to restore the affected area's function and appearance.

Radiation therapy uses high-energy X-rays or other radiation sources to kill cancer cells and shrink tumors. It can be administered externally, targeting the tumor from outside the body, or internally through the placement of radioactive materials near the tumor. Radiation therapy may be used before or after surgery, depending on the specific situation.

Chemotherapy involves the use of drugs to kill cancer cells throughout the body. It is often administered in cycles, alternating between treatment periods and rest periods to allow the body to recover. Different chemotherapy drugs may be combined to improve effectiveness and reduce the risk of resistance. The specific chemotherapy regimen for rhabdomyosarcoma depends on the patient's age, overall health, and the extent of the cancer.

Current Drugs for Rhabdomyosarcoma

Several drugs have been used in the treatment of rhabdomyosarcoma to improve patient outcomes. These drugs include:

  • Vincristine: This chemotherapy drug disrupts the growth of cancer cells by blocking their ability to divide.
  • Cyclophosphamide: It is an alkylating agent that interferes with cancer cell DNA replication, thereby preventing their growth and division.
  • Doxorubicin: Also known as Adriamycin, this drug works by damaging the DNA within cancer cells, leading to their death.
  • Ifosfamide: It is another alkylating agent that disrupts cancer cell DNA replication and growth.

Promising Future Drugs in Clinical Trials

Rhabdomyosarcoma trials are currently underway to explore potential new treatment options. Some of the promising drugs in late-stage clinical trials include:

  • Trabectedin: This drug is derived from a sea creature and has shown promise in treating advanced rhabdomyosarcoma by inhibiting tumor growth and inducing cancer cell death.
  • Voreloxin: It is a novel drug that targets specific enzymes involved in DNA replication, leading to cancer cell death.
  • Epacadostat: This drug is being studied in combination with other treatments to enhance the immune system's response against rhabdomyosarcoma.
  • Entinostat: It is a potential therapy for RMS that works by modifying gene expression in cancer cells, impairing their growth and division.

In conclusion, rhabdomyosarcoma is a rare form of cancer that primarily affects children and adolescents. Its diagnosis involves various medical assessments, and treatment approaches include surgery, radiation therapy, and chemotherapy. Current drugs used for rhabdomyosarcoma include vincristine, cyclophosphamide, doxorubicin, and ifosfamide. Ongoing clinical trials are exploring promising future drugs such as trabectedin, voreloxin, epacadostat, and entinostat to further improve treatment outcomes and provide hope for patients with this challenging disease.